Endometrial bleeding

D. Apter, D. T. Baird, J. Collins, H. O D Critchley, J. L H Evers, A. Glasier, P. Vercellini, K. Vogelsong, G. Benagiano, Pier Giorgio Crosignani, E. Diczfalusy, C. La Vecchia, A. Lanzone, S. O. Skouby, A. Volpe

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years. In every age group, medical treatment is the initial choice, but surgical treatment by endometrial destruction or hysterectomy is sometimes required. Benign causes of bleeding include fibroids and possibly adenomyosis, but the indications for treatment in each case depend upon the extent of bleeding, not the extent of the lesion. Breakthrough bleeding (BTB) with combined oral contraceptives commonly leads to discontinuation of the method. As BTB tends to improve with time, in the first 3 months of pill use, unless there are obvious underlying causes, women should be reassured that it will likely settle. BTB is often the reason for discontinuing progestogen-only contraception, and there is a need for effective means of treating unscheduled bleeding. Bleeding occurs in ∼3% of post-menopausal women, and the use of hormones increases the likelihood of bleeding by >5-fold. Knowledge of the underlying mechanisms of bleeding is essential to the development of effective treatment.

Original languageEnglish
Pages (from-to)421-431
Number of pages11
JournalHuman Reproduction Update
Volume13
Issue number5
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Hemorrhage
Metrorrhagia
Adenomyosis
Contraceptives, Oral, Combined
Curettage
Leiomyoma
Progestins
Therapeutics
Menopause
Hysterectomy
Contraception
Age Groups
Hormones
Health

Keywords

  • Endometrial bleeding
  • Heavy menstrual bleeding
  • Menstruation

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Apter, D., Baird, D. T., Collins, J., Critchley, H. O. D., Evers, J. L. H., Glasier, A., ... Volpe, A. (2007). Endometrial bleeding. Human Reproduction Update, 13(5), 421-431. https://doi.org/10.1093/humupd/dmm001

Endometrial bleeding. / Apter, D.; Baird, D. T.; Collins, J.; Critchley, H. O D; Evers, J. L H; Glasier, A.; Vercellini, P.; Vogelsong, K.; Benagiano, G.; Crosignani, Pier Giorgio; Diczfalusy, E.; La Vecchia, C.; Lanzone, A.; Skouby, S. O.; Volpe, A.

In: Human Reproduction Update, Vol. 13, No. 5, 09.2007, p. 421-431.

Research output: Contribution to journalArticle

Apter, D, Baird, DT, Collins, J, Critchley, HOD, Evers, JLH, Glasier, A, Vercellini, P, Vogelsong, K, Benagiano, G, Crosignani, PG, Diczfalusy, E, La Vecchia, C, Lanzone, A, Skouby, SO & Volpe, A 2007, 'Endometrial bleeding', Human Reproduction Update, vol. 13, no. 5, pp. 421-431. https://doi.org/10.1093/humupd/dmm001
Apter D, Baird DT, Collins J, Critchley HOD, Evers JLH, Glasier A et al. Endometrial bleeding. Human Reproduction Update. 2007 Sep;13(5):421-431. https://doi.org/10.1093/humupd/dmm001
Apter, D. ; Baird, D. T. ; Collins, J. ; Critchley, H. O D ; Evers, J. L H ; Glasier, A. ; Vercellini, P. ; Vogelsong, K. ; Benagiano, G. ; Crosignani, Pier Giorgio ; Diczfalusy, E. ; La Vecchia, C. ; Lanzone, A. ; Skouby, S. O. ; Volpe, A. / Endometrial bleeding. In: Human Reproduction Update. 2007 ; Vol. 13, No. 5. pp. 421-431.
@article{57855d4495084e02aa799500f41dc567,
title = "Endometrial bleeding",
abstract = "Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years. In every age group, medical treatment is the initial choice, but surgical treatment by endometrial destruction or hysterectomy is sometimes required. Benign causes of bleeding include fibroids and possibly adenomyosis, but the indications for treatment in each case depend upon the extent of bleeding, not the extent of the lesion. Breakthrough bleeding (BTB) with combined oral contraceptives commonly leads to discontinuation of the method. As BTB tends to improve with time, in the first 3 months of pill use, unless there are obvious underlying causes, women should be reassured that it will likely settle. BTB is often the reason for discontinuing progestogen-only contraception, and there is a need for effective means of treating unscheduled bleeding. Bleeding occurs in ∼3{\%} of post-menopausal women, and the use of hormones increases the likelihood of bleeding by >5-fold. Knowledge of the underlying mechanisms of bleeding is essential to the development of effective treatment.",
keywords = "Endometrial bleeding, Heavy menstrual bleeding, Menstruation",
author = "D. Apter and Baird, {D. T.} and J. Collins and Critchley, {H. O D} and Evers, {J. L H} and A. Glasier and P. Vercellini and K. Vogelsong and G. Benagiano and Crosignani, {Pier Giorgio} and E. Diczfalusy and {La Vecchia}, C. and A. Lanzone and Skouby, {S. O.} and A. Volpe",
year = "2007",
month = "9",
doi = "10.1093/humupd/dmm001",
language = "English",
volume = "13",
pages = "421--431",
journal = "Human Reproduction Update",
issn = "1355-4786",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Endometrial bleeding

AU - Apter, D.

AU - Baird, D. T.

AU - Collins, J.

AU - Critchley, H. O D

AU - Evers, J. L H

AU - Glasier, A.

AU - Vercellini, P.

AU - Vogelsong, K.

AU - Benagiano, G.

AU - Crosignani, Pier Giorgio

AU - Diczfalusy, E.

AU - La Vecchia, C.

AU - Lanzone, A.

AU - Skouby, S. O.

AU - Volpe, A.

PY - 2007/9

Y1 - 2007/9

N2 - Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years. In every age group, medical treatment is the initial choice, but surgical treatment by endometrial destruction or hysterectomy is sometimes required. Benign causes of bleeding include fibroids and possibly adenomyosis, but the indications for treatment in each case depend upon the extent of bleeding, not the extent of the lesion. Breakthrough bleeding (BTB) with combined oral contraceptives commonly leads to discontinuation of the method. As BTB tends to improve with time, in the first 3 months of pill use, unless there are obvious underlying causes, women should be reassured that it will likely settle. BTB is often the reason for discontinuing progestogen-only contraception, and there is a need for effective means of treating unscheduled bleeding. Bleeding occurs in ∼3% of post-menopausal women, and the use of hormones increases the likelihood of bleeding by >5-fold. Knowledge of the underlying mechanisms of bleeding is essential to the development of effective treatment.

AB - Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years. In every age group, medical treatment is the initial choice, but surgical treatment by endometrial destruction or hysterectomy is sometimes required. Benign causes of bleeding include fibroids and possibly adenomyosis, but the indications for treatment in each case depend upon the extent of bleeding, not the extent of the lesion. Breakthrough bleeding (BTB) with combined oral contraceptives commonly leads to discontinuation of the method. As BTB tends to improve with time, in the first 3 months of pill use, unless there are obvious underlying causes, women should be reassured that it will likely settle. BTB is often the reason for discontinuing progestogen-only contraception, and there is a need for effective means of treating unscheduled bleeding. Bleeding occurs in ∼3% of post-menopausal women, and the use of hormones increases the likelihood of bleeding by >5-fold. Knowledge of the underlying mechanisms of bleeding is essential to the development of effective treatment.

KW - Endometrial bleeding

KW - Heavy menstrual bleeding

KW - Menstruation

UR - http://www.scopus.com/inward/record.url?scp=34548170799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548170799&partnerID=8YFLogxK

U2 - 10.1093/humupd/dmm001

DO - 10.1093/humupd/dmm001

M3 - Article

VL - 13

SP - 421

EP - 431

JO - Human Reproduction Update

JF - Human Reproduction Update

SN - 1355-4786

IS - 5

ER -